Clinical trial Recruiting at 10 sites Observational Ages 18 and up

A hospital biobank of leftover clinical samples to support rapid diagnostic tests for emerging infectious threats.

Official title: Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions for Emerging Infectious Diseases and CBRN Threats - DiagRaMIE Biobanque

Run by Assistance Publique - Hôpitaux de Paris · NCT07411729 · Data updated 2026-11-12

This project will collect leftover samples from hospitalized adults to help test rapid diagnostic tools for emerging infectious diseases and CBRN threats.

More Non Communicable Chronic Diseases trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment800 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations10 sites (Le Kremlin-Bicêtre and 9 other locations)
StatusRecruiting
StartedJune 3, 2024
Main results expectedJune 1, 2026
Study endsJune 1, 2026
Registry record updatedFebruary 17, 2026
Trial IDNCT07411729 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) hospitalized at Bicêtre or Paul Brousse with residual clinical samples available, covered by the French social security system, and able to provide written consent (or with a legal representative) are ideal candidates.

Probably not a fit

Patients not hospitalized at the participating centers, those without residual samples, individuals under judicial protection or deprived of liberty, or those unable to consent without a translator are unlikely to directly benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The DiagRaMIE Biobank is a multicenter prospective registry that systematically collects leftover clinical specimens (blood, serum, plasma, respiratory samples, urine, cerebrospinal fluid, biopsies) and linked pseudonymized clinical and microbiological data from hospitalized adults at Bicêtre and Paul Brousse over a three-year inclusion period. No extra procedures or visits are required; samples obtained during routine care are stored securely for up to 20 years. The resource is intended to support development and validation of in vitro rapid diagnostic tests for emerging infectious diseases and CBRN threats, including WHO-prioritized pathogens. Data and specimens will be accessible to qualified developers and researchers to accelerate test evaluation and strengthen epidemic preparedness and patient management.

Why it matters

Potential benefit: If successful, the biobank could speed development and validation of rapid tests so infections are identified faster and outbreaks are controlled sooner.

How similar studies have gone: Hospital biobanks and specimen repositories have previously supported rapid development and validation of diagnostic tests (for example during COVID-19), although collections specifically focused on CBRN threats are less common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥ 18 years old) hospitalized in one of the participating centers at Bicêtre or Paul Brousse hospitals, for whom residual biological samples are available as part of routine care in one or more participating hospital departments.
* Covered by, or entitled to, the French social security system (excluding State Medical Aid - AME).
* Patient or legal representative/trusted person informed about the registry and having provided written consent to participate.

Exclusion Criteria:

* Patients under judicial protection (guardianship or curatorship).
* Patients deprived of liberty by judicial or administrative decision.
* Patients not speaking French and not accompanied by a translator.

Where it's running

  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
Show 4 more locations
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Bicêtre
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Paul Brousse
    Villejuif, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.